13
Views
1
CrossRef citations to date
0
Altmetric
Article

Resistance to Cryptococcus neoformans infection in the absence of CD4+ T cells

, , &
Pages 15-25 | Received 07 Jan 2003, Accepted 03 Jul 2003, Published online: 09 Jul 2009

References

  • Casadevall A, Perfect JR. Cryptococcus Neoformans . Washing-ton, DC: ASM Press, 1995.
  • Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Micro Rev 1995; 8: 515–548.
  • Hill JO, Aguirre KM. CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neofor-mans. J Immunol 1994; 152: 2344–2350.
  • Buchanan KL, Doyle HA. Requirement for CD4+ T Lympho-cytes in Host Resistance against Crptococcus neoformans in the Central Nervous System of Immunized Mice. Infect Immun 2000; 68: 456–462.
  • Aguirre K, Miller S. Class II-positive perivascular microglial cells mediate resistance to Cryptococcus neoformans brain infection. Glia 2002; 39(2): 184–188.
  • Parham P. The Immune System. NY and London: Garland Publishing and Elsevier Science, 2002.
  • Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991; 28: 254–260.
  • Cardell S, Merkenschlager M, Bodner H, Chan S, Cosgrove D, Benoist C, Mathis D. The immune system of mice lacking conventional MHC Class II molecules. Adv Immunol 1994; 55: 423–440.
  • Murphy JW, Cozad GC. Immunological unresponsiveness in-duced by cryptococcal polysaccharide assayed by the hemolytic plaque technique. Infect Immun 1972; 5: 896–901.
  • Edman JC, Kwon-Chung KJ. Isolation of the URA5 gene from Cryptococcus neoformans and its use as a selective marker for transformation. Mol Cell Biol 1990; 10: 4358–4544.
  • Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995; 63: 1725–1731.
  • Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microclial cells by v-ray-v-myc carry-ing retrovirus. J Neuroimmunol 1990; 27: 229–237.
  • Hill JO, Harmsen AG. Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ and CD8 + T cells. J Exp Med 1991; 173: 755–758.
  • Aguirre KM, Gibson GW. Differing requirement for inducible nitric oxide synthase activity in clearance of primary and secondary Cryptococcus neoformans infection. Med Mycol 2000; 38: 343–353.
  • Aguirrre KM, Sayles PC, Gibson GW, Johnson LL. Resistance to Cryptococcus neoformans is associated with an inflammatory response to Toxopolasma gondii in the central nervous system of mice. Infect Immun 1996; 65: 1688–1694.
  • Blasi E, Barluzzi R, Mazzola R. Role of nitric oxide and melanogenesis in the accomplishment of anticryptocccal activity by the BV2 microglial cell line. J Neuroimmunol 1995; 58: 111–116.
  • Barluzzi R, Brozetti A, Delfino D, Bistoni F, Blasi E. Role of the capsule in microglial cell-Cryptococcal interactions: Impairment of antifungal activity but not of secretory functions. Med Mycol 1998; 36: 189/197.1.
  • Panek RB, Benveniste EN. Class II MHC gene expression in microglia. Regulation by cytokines IFNg, TNFa and TGFb. J Immunol 1995; 154: 2846/2854.
  • Suzumura A, Mezitis SG, Gonatas NK, Silberberg DH. MHC antigen expression on bulk-isolated macrophage/microglia from newborn mouse brain: induction of Ia antigen expression by g- IFN. J. Neuroimmunol 1987; 15: 263/278.
  • Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE. The role of CD4 and CD8 T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukocyte Biol 1994; 55: 35/42.
  • Lee SC, Kress Y, Zhao JL, Dickson DW, Casadevall A. Cryptococcus neoformans survive and replicate in human microglia. Lab Invest 1995; 73: 871/879.
  • Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 2000; 68: 4225/4237.
  • Feldmesser M, Kress Y, Casadevall A. Intracellular crystal formation as a mechanism of cytotoxicity in murine pulmonary Cryptococcus neoformans infection. Infect Immun 2001; 69: 2223/ 2227.
  • Hoag KA, Lipscomb MF, Izzo AA, Street NE. IL-12 and IFNg are required for initiating protective TH1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Resp Cel Mol Biol 1997; 17: 733/739.
  • Kawakami K, Qureshi MH, Zhang T, Okamura H, Kurimoto M, Saito A. IL-18 protects mice against pulmonary and disseiminated infection with Cryptococcus neoformans by inducing IFN-g production. J Immunol 1997; 159: 5528/5534.
  • Levitz SM, North EA. Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans. J Med Vet Mycol 1997; 35: 229/236.
  • Lovchik JA, Lyons CR, Lipscomb MF. A role for g-IFNinducible nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am J Resp Cell Mol Biol 1995; 13: 116/124.
  • Mody CH, Tyler CL, Sitrin RG, Jackson G, Toews GB. IFNg activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Mol Biol 1991; 5: 19/26.
  • Olszewski MA, Huffnagle GB, Traynor TR, McDonald RA, Cook DN, Toews GB. Regulatory effects of macrophage inflammatory protein 1 alpha/CCL3 in the development of immunity to Cryptoocccus neoformans dependent expression of early inflammatory cytokines. Infect Immun 2001; 69: 6256/6263.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.